MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion.

Saved in:
Bibliographic Details
Title: MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion.
Authors: Ast V; Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, 07747 Jena, Germany.; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute Jena, 07745 Jena, Germany., Kordaß T; GMP & T Cell Therapy Unit, German Cancer Research Center, 69120 Heidelberg, Germany., Oswald M; Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, 07747 Jena, Germany.; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute Jena, 07745 Jena, Germany., Kolte A; Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, 07747 Jena, Germany.; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute Jena, 07745 Jena, Germany., Eisel D; GMP & T Cell Therapy Unit, German Cancer Research Center, 69120 Heidelberg, Germany., Osen W; GMP & T Cell Therapy Unit, German Cancer Research Center, 69120 Heidelberg, Germany., Eichmüller SB; GMP & T Cell Therapy Unit, German Cancer Research Center, 69120 Heidelberg, Germany., Berndt A; Institute of Forensic Medicine, Section Pathology, Jena University Hospital, 07747 Jena, Germany., König R; Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, 07747 Jena, Germany.; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute Jena, 07745 Jena, Germany.
Source: Oncotarget [Oncotarget] 2018 Oct 30; Vol. 9 (85), pp. 35559-35580. Date of Electronic Publication: 2018 Oct 30 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.26263